Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project.

Bjørge T, Lukanova A, Tretli S, Manjer J, Ulmer H, Stocks T, Selmer R, Nagel G, Almquist M, Concin H, Hallmans G, Jonsson H, Häggström C, Stattin P, Engeland A.

Int J Epidemiol. 2011 Dec;40(6):1667-77. doi: 10.1093/ije/dyr130. Epub 2011 Oct 7.

PMID:
21984693
2.

Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project.

Bjørge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J, Stocks T, Selmer R, Nagel G, Almquist M, Concin H, Hallmans G, Häggström C, Stattin P, Engeland A.

Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1737-45. doi: 10.1158/1055-9965.EPI-10-0230.

3.

Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can).

Ulmer H, Bjørge T, Concin H, Lukanova A, Manjer J, Hallmans G, Borena W, Häggström C, Engeland A, Almquist M, Jonsson H, Selmer R, Stattin P, Tretli S, Kleiner A, Stocks T, Nagel G.

Gynecol Oncol. 2012 May;125(2):330-5. doi: 10.1016/j.ygyno.2012.01.052. Epub 2012 Feb 10.

PMID:
22330614
4.

Prospective study on metabolic factors and risk of prostate cancer.

Häggström C, Stocks T, Ulmert D, Bjørge T, Ulmer H, Hallmans G, Manjer J, Engeland A, Nagel G, Almqvist M, Selmer R, Concin H, Tretli S, Jonsson H, Stattin P.

Cancer. 2012 Dec 15;118(24):6199-206. doi: 10.1002/cncr.27677. Epub 2012 Oct 22.

5.

Metabolic syndrome and endometrial carcinoma.

Bjørge T, Stocks T, Lukanova A, Tretli S, Selmer R, Manjer J, Rapp K, Ulmer H, Almquist M, Concin H, Hallmans G, Jonsson H, Stattin P, Engeland A.

Am J Epidemiol. 2010 Apr 15;171(8):892-902. doi: 10.1093/aje/kwq006. Epub 2010 Mar 10.

PMID:
20219764
6.

Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.

Borena W, Strohmaier S, Lukanova A, Bjørge T, Lindkvist B, Hallmans G, Edlinger M, Stocks T, Nagel G, Manjer J, Engeland A, Selmer R, Häggström C, Tretli S, Concin H, Jonsson H, Stattin P, Ulmer H.

Int J Cancer. 2012 Jul 1;131(1):193-200. doi: 10.1002/ijc.26338. Epub 2011 Sep 8.

7.

Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can).

Nagel G, Bjørge T, Stocks T, Manjer J, Hallmans G, Edlinger M, Häggström C, Engeland A, Johansen D, Kleiner A, Selmer R, Ulmer H, Tretli S, Jonsson H, Concin H, Stattin P, Lukanova A.

Br J Dermatol. 2012 Jul;167(1):59-67. doi: 10.1111/j.1365-2133.2012.10974.x. Epub 2012 Apr 24.

PMID:
22530854
8.

Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can).

Stocks T, Lukanova A, Bjørge T, Ulmer H, Manjer J, Almquist M, Concin H, Engeland A, Hallmans G, Nagel G, Tretli S, Veierød MB, Jonsson H, Stattin P; Metabolic Syndrome Cancer Project Me-Can Group.

Cancer. 2011 Jun 1;117(11):2398-407. doi: 10.1002/cncr.25772. Epub 2010 Dec 17.

9.

Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.

Furberg AS, Veierød MB, Wilsgaard T, Bernstein L, Thune I.

J Natl Cancer Inst. 2004 Aug 4;96(15):1152-60.

PMID:
15292387
10.

[Metabolic syndrome: prevalence, risk factors and mortality in a French population of 62 000 subjects].

Guize L, Thomas F, Pannier B, Bean K, Danchin N, Bénétos A.

Bull Acad Natl Med. 2006 Mar;190(3):685-97; discussion 697-700. French.

PMID:
17140103
11.

Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can).

Häggström C, Stocks T, Rapp K, Bjørge T, Lindkvist B, Concin H, Engeland A, Manjer J, Ulmer H, Selmer R, Tretli S, Hallmans G, Jonsson H, Stattin P.

Int J Cancer. 2011 Apr 15;128(8):1890-8. doi: 10.1002/ijc.25521.

12.

Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can).

Lindkvist B, Almquist M, Bjørge T, Stocks T, Borena W, Johansen D, Hallmans G, Engeland A, Nagel G, Jonsson H, Selmer R, Diem G, Häggström C, Tretli S, Stattin P, Manjer J.

Cancer Causes Control. 2013 Jan;24(1):107-16. doi: 10.1007/s10552-012-0096-6. Epub 2012 Nov 13.

PMID:
23149498
13.

A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study.

Borena W, Edlinger M, Bjørge T, Häggström C, Lindkvist B, Nagel G, Engeland A, Stocks T, Strohmaier S, Manjer J, Selmer R, Tretli S, Concin H, Hallmans G, Jonsson H, Stattin P, Ulmer H.

PLoS One. 2014 Feb 21;9(2):e89368. doi: 10.1371/journal.pone.0089368. eCollection 2014. Erratum in: PLoS One. 2014;9(7):e102291.

14.

Metabolic syndrome and mortality in older adults: the Cardiovascular Health Study.

Mozaffarian D, Kamineni A, Prineas RJ, Siscovick DS.

Arch Intern Med. 2008 May 12;168(9):969-78. doi: 10.1001/archinte.168.9.969.

PMID:
18474761
15.

Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.

Onat A, Hergenç G, Can G, Kaya Z, Yüksel H.

Metabolism. 2010 May;59(5):628-34. doi: 10.1016/j.metabol.2009.09.006. Epub 2009 Nov 14.

PMID:
19913840
16.

Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women.

Rodriguez C, Calle EE, Fakhrabadi-Shokoohi D, Jacobs EJ, Thun MJ.

Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):822-8.

17.

Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can).

Strohmaier S, Edlinger M, Manjer J, Stocks T, Bjørge T, Borena W, Häggström C, Engeland A, Nagel G, Almquist M, Selmer R, Tretli S, Concin H, Hallmans G, Jonsson H, Stattin P, Ulmer H.

PLoS One. 2013;8(1):e54242. doi: 10.1371/journal.pone.0054242. Epub 2013 Jan 23.

18.

Metabolic syndrome and rare gynecological cancers in the metabolic syndrome and cancer project (Me-Can).

Nagel G, Concin H, Bjørge T, Rapp K, Manjer J, Hallmans G, Diem G, Häggström C, Engeland A, Almquist M, Jonsson H, Selmer R, Stocks T, Tretli S, Ulmer H, Stattin P, Lukanova A.

Ann Oncol. 2011 Jun;22(6):1339-45. doi: 10.1093/annonc/mdq597. Epub 2010 Oct 21.

PMID:
20966183
19.

Metabolic syndrome is associated with gastric dysplasia.

Kim HY.

Eur J Gastroenterol Hepatol. 2011 Oct;23(10):871-5. doi: 10.1097/MEG.0b013e328349aa18.

PMID:
21811159
20.

Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.

Arnlöv J, Ingelsson E, Sundström J, Lind L.

Circulation. 2010 Jan 19;121(2):230-6. doi: 10.1161/CIRCULATIONAHA.109.887521. Epub 2009 Dec 28.

Supplemental Content

Support Center